WVP
CORV

Worth Venture Partners’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Worth Venture Partners’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-101,364
Closed -$203K – 134
2019
Q3 		$203K Buy
101,364
+14,107
+16% +$28.6K 0.12% 70
2019
Q2 		$249K Sell
87,257
-84,809
-49% -$217K 0.14% 63
2019
Q1 		$544K Buy
+172,066
New +$557K 0.31% 45
2018
Q4 		– Sell
-43,000
Closed -$173K – 203
2018
Q3 		$173K Buy
+43,000
New +$190K 0.13% 75

Other funds holding CORV

TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return